In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae (Q39478973)

12 September 2017

In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae (English)

1 reference

12 September 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

H Okamoto

1

1 reference

12 September 2017

S Miyazaki

2

1 reference

12 September 2017

K Tateda

3

1 reference

12 September 2017

Y Ishii

4

1 reference

12 September 2017

K Yamaguchi

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

45

1 reference

12 September 2017

11

1 reference

12 September 2017

3250-3252

1 reference

In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

Antibacterial activity of telithromycin (HMR 3647) in relation to in vitro simulated human plasma kinetics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90819

Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11600393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11600393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.45.11.3250-3252.2001

1 reference

12 September 2017

1 reference

12 September 2017

1 reference